These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19360302)

  • 1. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.
    Kaufmann R; Henklein P; Henklein P; Settmacher U
    Oncol Rep; 2009 May; 21(5):1261-7. PubMed ID: 19360302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells.
    Kaufmann R; Mussbach F; Henklein P; Settmacher U
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):965-73. PubMed ID: 21125404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.
    Mußbach F; Henklein P; Westermann M; Settmacher U; Böhmer FD; Kaufmann R
    J Cancer Res Clin Oncol; 2015 May; 141(5):813-25. PubMed ID: 25373316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and functional activity of thrombin receptors in the human lens.
    James C; Collison DJ; Duncan G
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):925-32. PubMed ID: 15728549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion.
    Kaufmann R; Oettel C; Horn A; Halbhuber KJ; Eitner A; Krieg R; Katenkamp K; Henklein P; Westermann M; Böhmer FD; Ramachandran R; Saifeddine M; Hollenberg MD; Settmacher U
    Carcinogenesis; 2009 Sep; 30(9):1487-96. PubMed ID: 19546160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
    Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
    Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
    Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
    Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
    Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
    J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
    Yang H; Wang M; Sun H; Zhu S; Jin J
    Pharmacology; 2019; 104(5-6):267-275. PubMed ID: 31434088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of IGF-I-induced osteoblast migration by (-)-epigallocatechin gallate through p44/p42 MAP kinase signaling.
    Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Otsuka T; Kozawa O
    Biomed Rep; 2018 Oct; 9(4):318-326. PubMed ID: 30233784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
    Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Ando S; Otani H; Yagi Y; Kawai K; Araki H; Fukuhara S; Inagaki C
    Respir Res; 2007 Apr; 8(1):31. PubMed ID: 17433115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.